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The choriocarcinoma syndrome is a rare and
serious complication of the choriocarcinoma
tumor, whose outcome relies on its early
recognition.
Case Report
A 24-year-old male, with no medical history,
noticed a gradual increase in the size of his left tes-
ticle over a period of six months. He consulted a
physician because he had headaches, vomiting,
fatigue, and mild dyspnea. On physical examin-
ation, he was found to be normotensive, with
oxygen saturation of 99%. His relevant laboratory
data were: Hematocrit 35.8%, LDH 2,345 IU/l (NV
210-420 IU/l), alfa-FP 76.7 IU/l (NV <11 IU/l),
HCG >200,000 IU/l (NV <4I U /l). Chest X-ray
evidenced multiple bilateral nodules of well-
deﬁned, regular borders (Figure 1). The brain
computed-tomography (CT) showed a lesion in
the left occipital region with peripheral edema
and midline displacement. He was diagnosed
with testicular cancer and an orchiectomy was
performed. Immediately afterwards, he was
treated with combined chemotherapy with bleomy-
cin, etoposide, and cisplatin. Three days later, he
presented with a cough, hemoptysis, a rapidly pro-
gressive dyspnea and respiratory failure. New lab-
oratory results showed his hematocrit had
decreased to 24%. A chest CT showed zones of
ground-glass opacity, mainly in the areas surround-
ing each pulmonary nodule (Figure 2). Broncho-
scopy could not be performed because of the
patient’s breathing difﬁculty. He continued the
chemotherapy treatment and showed clinical and
blood-gas improvement during the following
72 hours. Finally, the case was referred to the
oncology service. Afterwards, there were signs
of improvement in the chest CT, along with a
decrease in human chorionic gonadotropin (HCG)
values.
Discussion
Testicular tumors derived from germ cells are
the most common solid tumors in men between
15 and 35 years of age. Choriocarcinoma is the
most aggressive variant of this group of neoplasias
and is characterized serologically by the pro-
duction of large amounts of HCG.
Logothetis ﬁrst described the choriocarcinoma
syndromein1984.Thedistinctivefeatureofthissyn-
drome is bleeding at the metastatic site or sites.
1–4
When the lungs are affected, the clinical case is
similar to that of a diffuse alveolar hemorrhage.
Even though this syndrome was ﬁrst observed in
patients diagnosed with choriocarcinoma and
largetumorburden,caseswithhistologicalvariants
ofseminomahavealsobeenreported.
2–6Neverthe-
less,suchcasesshowedhighcirculatingHCGlevels,
which suggested the presence of choriocarcinoma
component in such neoplasias. Besides testicular
tumors, this syndrome has been described in germ-
cell tumors associated with a trophoblastic and
extratesticular disease.
6–7
Although the pathogenesis of the syndrome is
unknown, the damage may be triggered by che-
motherapy, as the symptoms usually develop a
few hours after the initiation of treatment.
7
Tumor invasion of small vessels was said to be
the cause of bleeding.
8 The prognosis of this syn-
drome is very poor, particularly in patients with
HCG values above 50,000 IU/l.
6
The diagnosis of the syndrome is initially based
on clinical suspicion. The chest radiography and
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1CT imaging will subsequently show nodular
images with irregular borders resulting from the
presence of surrounding alveolar hemorrhage.
The differential diagnosis should be performed
with chemotherapy toxicity (e.g., bleomycin) and
infections.
4
Since the severity of the bleeding may threaten
the patient’s life, the main goals of the treatment
are to ensure airway permeability and to achieve
hemodynamic stability. At present, no speciﬁc
therapy can be prescribed. Because of the short-
ness of breath, we were not able to conduct a
bronchoscopy so as to conﬁrm bleeding and at
the same time discard any infections.
We think that this syndrome should be borne in
mind among the physicianswho monitorand treat
patients for germ-cell tumors, avoiding a diagnos-
tic delay. We hope that this case report contributes
to the awareness of this complication, and there-
fore enables the prompt implementation of the
appropriate supportive measures that could have
a signiﬁcant impact on patient survival.
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Figure 1
Chest X-ray showed evidence of multiple bilateral
nodules of well-deﬁned, regular borders
Figure 2
A chest CT showed zones of ground-glass
opacity, mainly in the areas surrounding each
pulmonary nodule
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